Grandview Asset Management LLC Novartis Ag Transaction History

Grandview Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$85.24 - $94.15 $17,474 - $19,300	-205 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$83.5 - $98.47 $7,932 - $9,354	-95 Reduced 31.67%	205 $18,000
Q1 2021 May 06, 2021	BUY	$83.5 - $98.47 $25,050 - $29,541	300 New	300 $15,000
Q1 2020 Apr 09, 2020	SELL	$70.67 - $99.01 $615,111 - $861,783	-8,704 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$84.35 - $95.37 $49,260 - $55,696	-584 Reduced 6.29%	8,704 $826,000
Q3 2019 Nov 07, 2019	BUY	$85.54 - $94.26 $794,495 - $875,486	9,288 New	9,288 $799,000

1,434

138M

1.48M

1.55M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $235B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Grandview Asset Management LLC with notifications on news.